This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

We Called It: Wells Fargo's Securities Foray

Stocks in this article: WFC BAC PFE

So far this year, Wells-Wachovia has slipped to 35, performing eight deals worth $920 million through June 26. That compares with 42 deals worth $71.3 billion for all of last year. Top firms like Goldman, JPMorgan, BofA-Merrill, Citigroup and Deutsche Bank (DB) have also seen a decline, but not nearly as sharp.

"Wells is out of their league on this one," says Munson. "I think they're trying to be a Bank of America, and that's a mistake. There's only room for one Bank of America and one JPMorgan and one Goldman Sachs."

Whether Wells will be able to find its niche in the investment banking space is yet to be seen. It will take a good deal of time to solidify a reputation for the brand that is to be unveiled in coming days. Juneja, the JPMorgan analyst, noted that since Wells is moving forward with its Wells-like limitations, "it will have to be a market maker in the products it focuses on."

Tried and true believers have faith that the firm will succeed.

Richard Bove, an analyst at Rochdale Securities, calls the integration "a sizable challenge," but says the Wachovia acquisition was "the right move," largely because of its capital markets business and gigantic sales force.

"Wells management has a long track record of delivering on its promises ... Plus, betting on Wells abilities has always made sense and it makes sense now," Bove wrote in a report earlier this year.

5 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs